Skip to content

Form 4 filed by Keller Eric L.

Keller Eric L. filed this Form 4 on Retension Pharmaceuticals, Inc. with 6 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-13 22:12:28 UTC.

Accession
0001213900-26-109160
Filed
2026-10-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Retension Pharmaceuticals, Inc. (CIK 2002988)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-13P bought+20,800$12423,377D
Common Stock 2026-10-13C converted+9,662433,039D
Common Stock 2026-10-13C converted+31,368464,407D
Stock Option (right to buy) derivative2026-10-13A granted+255,174$0255,174D
Series A Convertible Preferred Stock derivative2026-10-13C converted-9,6620D
Series B Convertible Preferred Stock derivative2026-10-13C converted-31,3680D